{ Health Economics }
A project isn’t a success until it moves the needle on your business
At DaVita Clinical Research (DCR) Health Economics, we don’t consider a project a success unless it has a real and measurable impact on your business. A publication or model needs to be accessible to your field force and must provide data that is meaningful and easily assimilated by your end customers.
Our team brings with it the analytic and commercial experience that only comes from having held leadership positions at the world’s largest pharmaceutical and biotechnology companies, leading the world’s largest drug and biotech franchises. We understand the data and tools necessary to support access, reimbursement, and utilization of multi-billion dollar products. We bring with us firsthand experience with FDA filings, FDA drug advisory committees, submissions, and presentations to key US and European government agencies (FDA, CMS, EMEA, NICE). We have created successful dossiers and presented to P&T committees at the leading managed care organizations (Wellpoint, United, Aetna, Cigna, Kaiser, etc.). We have conducted the analytics and created briefings that have helped to shape current healthcare policy.
Our products and services include:
- Economic modeling
- Data analytics and biostatistics
- Prospective study design and execution
- Psychometric development and validation
- Commercial reimbursement and formulary placement
- Policy analytics
Where many companies can design and execute a study or model, we succeed by translating that into tools and products that change behavior.
